Cours ESSA Pharma Inc Toronto S.E.
Actions
EPI
CA29668H1047
Recherche biotechnologique et médicale
CA 2024 * | - | CA 2025 * | - | Capitalisation | 368 M 270 M 246 M |
---|---|---|---|---|---|
Résultat net 2024 * | -48 M -35,13 M -32,1 M | Résultat net 2025 * | -78 M -57,09 M -52,17 M | VE / CA 2024 * | - |
Trésorerie nette 2024 * | - 0 0 | Trésorerie nette 2025 * | - 0 0 | VE / CA 2025 * | - |
PER 2024 * |
-7,66
x | PER 2025 * |
-5,45
x | Employés | - |
Rendement 2024 * |
-
| Rendement 2025 * |
-
| Flottant | 97,72% |
Dernier transcript sur ESSA Pharma Inc
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
David Parkinson
CEO | Chief Executive Officer | 73 | 24/06/15 |
David Wood
DFI | Director of Finance/CFO | 66 | 01/10/13 |
Peter Virsik
COO | Chief Operating Officer | - | 01/08/16 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Franklin Berger
BRD | Director/Board Member | 74 | 05/03/15 |
Sanford Zweifach
BRD | Director/Board Member | 68 | 31/07/19 |
Richard Glickman
CHM | Chairman | 65 | 01/10/10 |
Varia. 1 janv. | Capi. | |
---|---|---|
+1,51% | 42,75 Md | |
+49,22% | 41,61 Md | |
+8,57% | 41,34 Md | |
-12,36% | 26,59 Md | |
+8,92% | 25,49 Md | |
-25,13% | 18,12 Md | |
+29,17% | 12,24 Md | |
-3,12% | 11,76 Md | |
+6,35% | 11 Md |